Mark McDade
Mark McDade is Co-founder and Partner at Qiming Venture Partners USA. He was EVP and Chief Operating Officer at UCB and CEO at PDL BioPharma. He was Chief Executive Officer at Signature BioScience, Co-founder and COO at Corixa Corporation, and COO at Boehringer Mannheim Therapeutics. He is chairman of Icosavax, a director of Lupin Ltd. and a trustee of the National Marine Sanctuary Foundation, and was chairman of Aimmune Therapeutics and a director of Dermira, Inc.
-
Qiming Venture Partners USA Co Founder and Partner 2017–present · current
-
UCB EVP and Chief Operating Officer 2008–2016 · past
-
PDL BioPharma CEO 2002–2007 · past
-
Signature BioScience Chief Executive Officer 2001–2002 · past
-
Corixa Corporation Co-founder and COO 1994–2000 · past
-
Boehringer Mannheim Therapeutics COO 1992–1994 · past
Education
-
Harvard Business School 1982–1984
-
Dartmouth College Bachelor of Arts (B.A.), History · 1973–1977